Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals

Rekvina Laboratories Ltd Stock Analysis

Small Cap
Evaluated by 13 users | BSE: 526075 | NSE: |

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
Return on Capital Employed 00-5.09%-1.28%4.21%2.62%3.35%0.65%-10.41%-3.29%-12.59%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 00000.
Y-o-Y Gr. Rt.-NANANANA0%0%-62.5%100%-100%NA-
Adjusted EPS (Rs.) 00-0.05-
Y-o-Y Gr. Rt.-NANANANA0%33.3%-75%-1000%NANA-
Book Value per Share (Rs.)
Adjusted Net Profit 00000000-0.10-0.10
Net Op. Cash Flow (Rs. Cr.) 00000000000-
Debt to Cash Flow from Ops 0000000-0.47-0.2316.87-8.94-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Rekvina Laboratories Ltd. should be analysed on a Standalone basis
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales NA-100%-100%NA
Adjusted EPS NA-234.1%-335.1%NA
Book Value per Share 0-9.3-10.4-17.3
Share Price - -9.2% -4.1% 7.9%
Key Financial Parameter
Performance Ratio Colour Code Guide
Return on Equity (%) 00-5.1-
Operating Profit Margin (%) 000038.6226.2435.915.4-89.93000
Net Profit Margin (%) 000019.5121.2128.8412.19-90.07000
Debt to Equity 00000000.020.020.350.510
Working Capital Days 00001,4531,6972,0045,0592,54900-
Cash Conversion Cycle 0000-6,422-67,2190-1,342-4,94000-
Loading price chart...
Entity Percentage Holding
Promoters 41.30%
Non-Institutions 58.70%
Pledged *
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Rekvina Laboratories Ltd's earnings have declined by -234.1%, whereas share price has declined -9.2% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Data is not available for this company

Data is not available for this company.

No data to display
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323